|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/48 | |||
| A61K 31/7048 |
| (11) | Patento numeris | 2363113 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11165824.1 |
| Europos patento paraiškos padavimo data | 2007-12-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-09-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-08-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 872497 P | 2006-12-04 | US |
| (72) |
Liang, Likan, US
Bhatt, Padmanabh, US
Wang, Hua, US
|
| (73) |
Supernus Pharmaceuticals, Inc.,
1550 East Gude Drive, Rockville, MD 20850,
US
|
| (54) | Enhanced immediate release formulations of topiramate |
| Enhanced immediate release formulations of topiramate |